苏州百迈生物医药

Baimai Biomedical is a biotechnology company specializing in organoid technology and precision medicine, based in the Suzhou Industrial Park. The company has established a leading organoid-on-a-chip platform that combines microfluidic technology with 3D cell culture to create highly physiological models for drug discovery and clinical diagnostics. Their core business includes providing high-throughput drug screening services for pharmaceutical companies and personalized medication guidance for cancer patients. By utilizing patient-derived organoids, Baimai Biomedical offers a more accurate prediction of clinical drug responses compared to traditional cell lines or animal models. The company is dedicated to accelerating the development of innovative therapies and improving patient outcomes through advanced bio-modeling.